Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making | ||
| dc.conicet.organizacion | Universidad Abierta Interamericana | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Universidad Abierta Interamericana | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.contributor.author | Pirola, Carlos Jose | |
| dc.contributor.author | Sookoian, Silvia Cristina | |
| dc.date.issued | 2023-06 | |
| dc.description.abstract | Introduction: nonalcoholic fatty liver disease (NAFLD) is a complex disorder resulting from intricate relationships with diverse cardiometabolic risk factors and environmental factors. NAFLD may result in severe chronic liver damage and potentially declining liver function. Areas covered: Accumulated knowledge over the last decade indicates that the disease trajectory presents substantial heterogeneity. In addition, overlapping features with the diseases of the metabolic syndrome, combined with heterogeneity in disease mechanisms, further complicates NAFLD diagnosis and prognosis, and hampers progress in biomarker and pharmacological discoveries. Here, we explore solving the heterogeneous clinical landscape of NAFLD by cluster analysis of molecular signatures that serve as a proxy for disease stratification into molecular sub-types. First, we collected information on NAFLD and metabolic syndrome-associated protein-coding genes by data mining the literature. Next, we performed pathways enrichment and cluster analyses to decipher and dissect the different patterns of phenotypic heterogeneity. Our approach showed unique biological pathways for every clinical subtype/group, namely NAFLD + obesity, NAFLD + arterial hypertension, NAFLD + dyslipidemia, and NAFLD + type 2 diabetes. | es |
| dc.description.fil | Fil: Pirola, Carlos Jose. Universidad Abierta Interamericana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Sookoian, Silvia Cristina. Universidad Abierta Interamericana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Pirola, Carlos Jose; Sookoian, Silvia Cristina; Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making; Taylor & Francis; Expert Review of Gastroenterology and Hepatology; 17; 4; 6-2023; 317-324 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1747-4132 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/220728 | |
| dc.journal.number | 4 | es |
| dc.journal.pagination | 317-324 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Expert Review of Gastroenterology and Hepatology | es |
| dc.journal.volume | 17 | es |
| dc.language.iso | eng | es |
| dc.publisher | Taylor & Francis | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/abs/10.1080/17474124.2023.2191190 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1080/17474124.2023.2191190 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | ARTERIAL HYPERTENSION | es |
| dc.subject | DYSLIPIDEMIA | es |
| dc.subject | GENETICS | es |
| dc.subject | HETEROGENEITY | es |
| dc.subject | METABOLIC SYNDROME | es |
| dc.subject | NAFLD | es |
| dc.subject | NASH | es |
| dc.subject | OBESITY | es |
| dc.subject | OMICS | es |
| dc.subject | TYPE 2 DIABETES | es |
| dc.subject.classification | Gastroenterología y Hepatología | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.2b6b98ac-9f42-43bb-8e96-462c49db514d_B.pdf
- Tamaño:
- 5.78 MB
- Formato:
- Adobe Portable Document Format